Kong AN - Search Results

1

Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition.

Lin W, Hong JL, Shen G, Wu RT, Wang Y, Huang MT, Newmark HL, Huang Q, Khor TO, Heimbach T, Kong AN. Lin W, et al. Among authors: kong an. Biopharm Drug Dispos. 2011 Mar;32(2):65-75. doi: 10.1002/bdd.734. Epub 2010 Dec 16. Biopharm Drug Dispos. 2011. PMID: 21341276 Free PMC article.

2

Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC).

Keum YS, Owuor ED, Kim BR, Hu R, Kong AN. Keum YS, et al. Among authors: kong an. Pharm Res. 2003 Sep;20(9):1351-6. doi: 10.1023/a:1025737622815. Pharm Res. 2003. PMID: 14567627

3

Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.

Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV. Reddy BS, et al. Among authors: kong an. Cancer Res. 2006 Apr 15;66(8):4542-6. doi: 10.1158/0008-5472.CAN-05-4428. Cancer Res. 2006. PMID: 16618783

4

Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.

Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. Khor TO, et al. Among authors: kong an. Cancer Res. 2006 Dec 15;66(24):11580-4. doi: 10.1158/0008-5472.CAN-06-3562. Cancer Res. 2006. PMID: 17178849

5

Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.

Nair S, Hebbar V, Shen G, Gopalakrishnan A, Khor TO, Yu S, Xu C, Kong AN. Nair S, et al. Among authors: kong an. Pharm Res. 2008 Feb;25(2):387-99. doi: 10.1007/s11095-007-9364-7. Epub 2007 Jul 27. Pharm Res. 2008. PMID: 17657594

6

Pharmacogenomic profile of soy isoflavone concentrate in the prostate of Nrf2 deficient and wild-type mice.

Barve A, Khor TO, Nair S, Lin W, Yu S, Jain MR, Chan JY, Kong AN. Barve A, et al. Among authors: kong an. J Pharm Sci. 2008 Oct;97(10):4528-45. doi: 10.1002/jps.21311. J Pharm Sci. 2008. PMID: 18236473

7

Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.

Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN. Li W, et al. Among authors: kong an. Biochem Pharmacol. 2008 Dec 1;76(11):1485-9. doi: 10.1016/j.bcp.2008.07.017. Epub 2008 Jul 23. Biochem Pharmacol. 2008. PMID: 18694732 Free PMC article. Review.

8

Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway.

Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN. Lin W, et al. Among authors: kong an. Biochem Pharmacol. 2008 Oct 15;76(8):967-73. doi: 10.1016/j.bcp.2008.07.036. Epub 2008 Aug 7. Biochem Pharmacol. 2008. PMID: 18755157 Free PMC article.

9

Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation.

Cheung KL, Khor TO, Kong AN. Cheung KL, et al. Among authors: kong an. Pharm Res. 2009 Jan;26(1):224-31. doi: 10.1007/s11095-008-9734-9. Epub 2008 Oct 8. Pharm Res. 2009. PMID: 18841446

10

Dietary cancer chemopreventive agents - targeting inflammation and Nrf2 signaling pathway.

Khor TO, Yu S, Kong AN. Khor TO, et al. Among authors: kong an. Planta Med. 2008 Oct;74(13):1540-7. doi: 10.1055/s-0028-1088303. Epub 2008 Oct 20. Planta Med. 2008. PMID: 18937168 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters